SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-23-003470
Filing Date
2023-02-14
Accepted
2023-02-14 17:12:28
Documents
1
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3a.html 3/A  
1 AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3a.xml 3/A 3511
  Complete submission text file 0001062993-23-003470.txt   4932
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address
Hackman Jeffrey S. (Reporting) CIK: 0001926254 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41403 | Film No.: 23631508